Wikipedia -WSS

Wikipedia

author：comprehensive 2025-09-03 11:50:56 - browse：63583

Eli Lilly headquarters — Kristoffer Tripplaar/AP

The drug giant Eli Lilly said Thursday that its diabetes drug Mounjaro helped patients with the condition lose 15.7% of their body weight in a clinical trial, a result that Wall Street analysts expect to pave the way for the therapy’s approval as a weight loss treatment.

Mounjaro is the latest drug in a class known as GLP-1s or incretins — the same class as Novo Nordisk’s Ozempic, which has become a sensation because of its ability to help patients lose weight. Mounjaro has shown the potential to lead to even greater weight loss than Ozempic, and industry experts expect that it will eventually generate many billions of dollars in annual sales. Analysts at SVB Securities projected in December that Mounjaro sales could reach $26.4 billion by 2030.

Eli Lilly on Thursday also announced quarterly earnings of $1.64 per share, adjusted for one-time items, slightly below analyst expectations, on sales of $6.96 billion. Sales were hurt because of a comparison to a year ago, when the company’s Covid-19 monoclonal antibodies were still on the market. Mounjaro sales for the first quarter were $586 million, largely for people with diabetes, compared to an analyst consensus of $433.2 million.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Bernie Sanders bashes nonprofit hospitals over their tax breaks

Wikipedia

WSS

Eight reasons why you should get an updated Covid vaccine

Kaiser Permanente unions announce official strike date

Biogen shutters digital health group, ends Apple study, in cost cutting move

Kaiser Permanente unions announce official strike date

How should state employee insurance handle Wegovy?

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

leisure time

Wikipedia

hotspot

Malaria cases in Florida and Texas: Here’s what you need to know

STAT Readout Newsletter: Today in biotech, life science news

Medical leaders decry Supreme Court decision on affirmative action

Wellcome Trust names Røttingen as its new CEO

How one medical school became remarkably diverse

Cigna to pay $172 million to settle Medicare Advantage fraud probe

Apple is now the first public company to be valued at $3 trillion

European regulators recommend Amylyx's ALS drug be rejected

Walensky prepares to leave CDC — and Congress — behind

UnitedHealth’s Q3 profit jumps as medical costs rise more slowly

leisure time

Akero's treatment for NASH falls short in cirrhosis study

Ionis has late

Ionis has late

How doctors and nurses shape Google's AI

After a drawn out lobbying fight, ARPA

What the Wegovy shortage looks like for doctors — and for patients

Wikipedia

explore

leisure time

Wikipedia